Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
10 mM to specifically inhibit transport of nucleosides mediated by equilibrative nucleoside transporters 1 (ENT1) and 2 (ENT2)
Sabine Bachmaier
PubMed PMID: 10900073
[Effects of a protein kinase C inhibitor combined with cisplatin on non-small cell lung cancer
Research on isosorbide mononitrate as a cervical ripener to reduce time at hospital to birth is supportive
(R)-SLV 319 703 10 mM to specifically inhibitKi: 7. 8 and 7943 nM for CB1 and CB2 receptors, respectively by SLV 319 (R) SLV 319 is a CB1 receptor antagonist. Central cannabinoid (CB1) receptor antagonists can be used in the treatment of various diseases including cognitive disorders, neuroinflammatory disorders, obesity, septic shock, psychosis, addiction, as well as gastrointestinal disorders. In vitro: (R) SLV 319 is the inactive enantiomer of SLV 319 with 100 fold less affinity for the CB1
US$ 5750.00
US$ 1900.00
US$ 3900.00
US$ 9750.00
US$ 1200.00
US$ 12750.00
US$ 600.00
US$ 1400.00
US$ 1250.00
US$ 700.00
US$ 1400.00
US$ 600.00